UbiquiTx
PrivateLast Round
Grant
Aug 15, 2025
Total Funding Raised
$1.63M
Company Overview
UbiquiTx operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in August 2025.
UbiquiTx is a biotechnology company that develops an AI-native platform for programmable modulation of the proteome to create targeted protein degradation therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
UbiquiTx Comparables
Compare UbiquiTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celeris Therapeutics | 80% | |
| Avilar Therapeutics | 77% | |
| Magnet Biomedicine | 77% |
For institutional investors. Book with your work email.
UbiquiTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 15, 2025 | ||||
| Accelerator | Nov 21, 2024 | ||||
| Grant | Jul 15, 2024 | ||||
| Grant | Jul 10, 2024 | ||||
| Grant | Mar 1, 2024 |
For institutional investors. Book with your work email.
UbiquiTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| National Institute of Allergy and Infectious Diseases | Grant |
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| Merck Digital Sciences Studio | Accelerator |
| New Jersey Innovation Institute | Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2025
$391K grant received from NIAAA.
- Nov 21, 2024
Merck & Co., Inc. and Northpond Ventures participated in the round.
For institutional investors. Book with your work email.
UbiquiTx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about UbiquiTx's valuation, stock price, and market status.
Is UbiquiTx a public or private company?
UbiquiTx is a private company.
What is the current stock price of UbiquiTx?
UbiquiTx is a private company, so its shares have no public market price. Caplight tracks UbiquiTx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is UbiquiTx worth (valuation)?
Valuation information for UbiquiTx is not publicly available.
Can I buy UbiquiTx stock?
UbiquiTx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was UbiquiTx's last funding round?
UbiquiTx's most recent funding round was Grant on August 15, 2025.
Who are the main investors in UbiquiTx?
Key investors in UbiquiTx include National Cancer Institute, National Institute of Allergy and Infectious Diseases, Northpond Ventures, McKesson Ventures, National Institute on Alcohol Abuse and Alcoholism.
Will UbiquiTx IPO soon?
No public IPO plans have been announced for UbiquiTx.
How can I track UbiquiTx secondary market activity?
Caplight tracks bids, offers, and trades in UbiquiTx's shares on secondary markets.